Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Baxter
Argus Health
QuintilesIMS
Cipla
Mallinckrodt
McKesson
Colorcon

Generated: November 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INSULIN GLULISINE RECOMBINANT

« Back to Dashboard

INSULIN GLULISINE RECOMBINANT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis Us APIDRA insulin glulisine recombinant INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021629 NDA Sanofi-Aventis U.S. LLC 0088-2500-33 1 VIAL, GLASS in 1 CARTON (0088-2500-33) > 10 mL in 1 VIAL, GLASS
Sanofi Aventis Us APIDRA insulin glulisine recombinant INJECTABLE;IV (INFUSION), SUBCUTANEOUS 021629 NDA Sanofi-Aventis U.S. LLC 0088-2502-05 5 SYRINGE, PLASTIC in 1 CARTON (0088-2502-05) > 3 mL in 1 SYRINGE, PLASTIC
Sanofi Aventis Us APIDRA SOLOSTAR insulin glulisine recombinant INJECTABLE;SUBCUTANEOUS 021629 NDA Sanofi-Aventis U.S. LLC 0088-2500-33 1 VIAL, GLASS in 1 CARTON (0088-2500-33) > 10 mL in 1 VIAL, GLASS
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
UBS
Moodys
Harvard Business School
Farmers Insurance
Merck
Queensland Health
Federal Trade Commission
US Department of Justice